Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Consumers Challenge DMAA Safety After DOD Bans Products

This article was originally published in The Tan Sheet

Executive Summary

Complaints against GNC Holdings Inc., manufacturer Cellucor Sports Nutrition and Woodbolt Distribution and against USPLabs rely on DOD’s decision to ban sales of the product at military exchanges and moves by Canadian regulators to support their arguments.

Advertisement

Related Content

DMAA Targeted In N.Y. Ban Effort, USP Labs Settles
DMAA Targeted In N.Y. Ban Effort, USP Labs Settles
Senate Appropriators Call For Botanical Identity Testing Guidance
Senate Appropriators Call For Botanical Identity Testing Guidance
Class Action Claims Often Follow Regulatory Action, Industry Litigation
U.S. Military Investigates Supplement Ingredient DMAA, Bans Sales
New Dietary Ingredient Notification Draft Guidance Must Be Withdrawn – CRN and CHPA
Synthetics Stance In NDI Guidance Raises Red Flag For Industry

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS105618

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel